Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-08-01
著者
-
CAMPOS Susana
Department of Gynecology Oncology, Dana Farber Cancer Institute
-
BERLIN Suzanne
Department of Gynecology Oncology, Dana Farber Cancer Institute
-
PARKER Leroy
Department of Breast Oncology, Dana Farber Cancer Institute
-
CHEN Wendy
Department of Breast Oncology, Dana Farber Cancer Institute
-
BUNNELL Craig
Department of Breast Oncology, Dana Farber Cancer Institute
-
ATKINSON Tina
Department of Gynecology Oncology, Dana Farber Cancer Institute
-
LEE Julie
Department of Gynecology Oncology, Dana Farber Cancer Institute
-
MATULONIS Ursula
Department of Gynecology Oncology, Dana Farber Cancer Institute
-
HIRSCH Michelle
Department of Pathology, Brigham and Women's Hospital
-
HARRIS Lyndsay
Department of Medical Oncology, Yale University
-
KRASNER Carolyn
Department of Gynecology Oncology, Massachusetts General Hospital
-
Atkinson Tina
Department Of Gynecology Oncology Dana Farber Cancer Institute
-
Parker Leroy
Department Of Breast Oncology Dana Farber Cancer Institute
-
Lee Julie
Department Of Gynecology Oncology Dana Farber Cancer Institute
-
Chen Wendy
Department Of Breast Oncology Dana Farber Cancer Institute
-
Campos Susana
Department Of Gynecology Oncology Dana Farber Cancer Institute
-
Bunnell Craig
Department Of Breast Oncology Dana Farber Cancer Institute
-
Bunnell Craig
Department Of Adult Oncology Dana-farber Cancer Institute And Harvard Medical School
-
Harris Lyndsay
Department Of Medical Oncology Yale University
-
Berlin Suzanne
Department Of Gynecology Oncology Dana Farber Cancer Institute
-
Hirsch Michelle
Department Of Pathology Brigham And Women's Hospital
-
Lee Julie
Department Of Chemistry-baker Laboratory
-
Krasner Carolyn
Department Of Gynecology Oncology Massachusetts General Hospital
-
Matulonis Ursula
Department Of Gynecology Oncology Dana Farber Cancer Institute
関連論文
- Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer
- A Cholesteryl Ester Transfer Protein Inhibitor from an Insect-associated Fungus
- Current Perspectives for Treatment of Breast Cancer